Results about: innovation
IRB Barcelona promotes research valorisation and commercialisation thanks to a grant from ACCIÓ.
The company concludes a 2.2 million € round led by ”la Caixa” through Caixa Capital Risc. Also participating in the operation were Ysios Capital and Fundación Vila Casas.
Inbiomotion, a spin off founded by IRB Barcelona's group leader, Roger Gomis, develops diagnostic products for predicting risks that cancer patients may suffer bone metastasis.
The goal is to speed up the transfer of technologies developed in the six BIST research institutes to the marketplace.